Stock Market News

Curevac Ceo Says Co Aims To Finish Phase Iii Trial For Covid-19 Vaccine In Q1, Sees Approval In Early Q2 At The Latest - Handelsblatt

January 11, 2021 at 02:20 am

CUREVAC CEO SAYS CO AIMS TO FINISH PHASE III TRIAL FOR COVID-19 VACCINE IN Q1, SEES APPROVAL IN EARLY Q2 AT THE LATEST - HANDELSBLATT

Strategy: Is China becoming unattractive again with Trump and Vance?

Wall Street: Soxx plunges to its lowest level since 03/2022

Discover Financial quarterly profit jumps on higher interest income

Wheat Futures Climb on Hopes for Better Export Sales -- Daily Grain Highlights

Nymex Overview : Crude Oil Contracts Lead Petroleum Futures Higher -- OPIS

Global markets live: Adidas, TSMC, Vale, HSBC, J&J...

Apax, Bain and CVC exploring potential bids for SoftwareOne, sources say

Gold Futures Glitter on Record High With Further Gains in Sight -- 2nd Update

For stocks, is AI the Emperor's new clothes?: McGeever

CAC40: close to equilibrium, erases part of losses